Target intelligence / Profile preview

Angiotensin-Converting Enzyme (ACE)

Target
ACE
Molecular classification
Enzyme, Zinc metalloprotease
01

Overview

Angiotensin-converting enzyme (ACE) is a zinc-dependent metalloproteinase that plays a central role in the renin–angiotensin system (RAS), which regulates blood pressure and fluid balance in the body. ACE converts angiotensin I to angiotensin II, a potent vasoconstrictor, and degrades bradykinin, a vasodilator. ACE is targeted pharmacologically by ACE inhibitors, which are widely used antihypertensive drugs.

Other names
Kininase II
02

Mechanism of action

ACE inhibitors block the conversion of angiotensin I to angiotensin II and prevent the degradation of bradykinin, leading to vasodilation and decreased blood pressure.

03

Biological functions

Regulation of blood pressureRegulation of fluid balanceConversion of Angiotensin I to Angiotensin IIDegradation of bradykininRegulation of vascular toneModulation of inflammationModulation of vascular permeability
04

Disease associations

Cardiovascular diseaseKidney diseaseHypertensionHeart failure
05

Interacting drugs

Captopril

2 more in the full profile.

Beyond the preview

Go deeper on Angiotensin-Converting Enzyme (ACE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Angiotensin-Converting Enzyme (ACE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call